JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
iShares 10-20 Year Treasury Bond ETF
TLH
$10.7B
| $1.26M | ﹤0.01% |
11,002
+8,304
| +308% | +$934K |
2019 Q2
15 quarters
|
|
3702
HBT Financial
HBT
$1.29B
| $1.26M | ﹤0.01% |
63,828
-892
| -1% | -$18.6K |
2019 Q4
13 quarters
|
|
3703
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$428M
| $1.26M | ﹤0.01% |
36,900
+2,360
| +7% | +$79.3K |
2020 Q4
9 quarters
|
|
3704
Viridian Therapeutics
VRDN
$2.07B
| $1.26M | ﹤0.01% |
49,377
-122,982
| -71% | -$3.94M |
2021 Q4
5 quarters
|
|
|
SONX
3705
DELISTED
Sonendo, Inc.
SONX
| $1.26M | ﹤0.01% |
627,895
+259,082
| +70% | +$588K |
2022 Q4
1 quarter
|
|
|
EHAB
3706
DELISTED
Enhabit
EHAB
| $1.25M | ﹤0.01% |
90,202
+13,467
| +18% | +$194K |
2022 Q3
2 quarters
|
|
|
LSEA
3707
DELISTED
Landsea Homes
LSEA
| $1.25M | ﹤0.01% |
207,074
-8,162
| -4% | -$52.3K |
2021 Q1
8 quarters
|
|
|
VTNR
3708
DELISTED
Vertex Energy, Inc
VTNR
| $1.25M | ﹤0.01% |
127,055
+27,611
| +28% | +$219K |
2022 Q2
3 quarters
|
|
|
EMBJ
3709
Embraer S.A. ADS
EMBJ
$12.8B
| $1.25M | ﹤0.01% |
76,502
-456,289
| -86% | -$6.07M |
2013 Q2
39 quarters
|
|
3710
Expro Ltd
XPRO
$1.75B
| $1.25M | ﹤0.01% |
68,277
+21,958
| +47% | +$431K |
2017 Q4
21 quarters
|
|
3711
ARK Next Generation Technology ETF
ARKW
$2.1B
| $1.25M | ﹤0.01% |
23,313
-18,156
| -44% | -$884K |
2020 Q1
12 quarters
|
|
3712
Xeris Biopharma Holdings
XERS
$1.84B
| $1.25M | ﹤0.01% |
766,291
+671,873
| +712% | +$841K |
2018 Q3
18 quarters
|
|
3713
Banco Santander
SAN
$198B
| $1.24M | ﹤0.01% |
336,879
+19,418
| +6% | +$69.1K |
2013 Q2
39 quarters
|
|
3714
Jakks Pacific
JAKK
$318M
| $1.23M | ﹤0.01% |
71,283
+12,522
| +21% | +$235K |
2021 Q1
8 quarters
|
|
|
WOW
3715
DELISTED
WideOpenWest
WOW
| $1.23M | ﹤0.01% |
115,777
+7,454
| +7% | +$80.7K |
2017 Q4
21 quarters
|
|
3716
Sportsman's Warehouse
SPWH
$43.8M
| $1.23M | ﹤0.01% |
145,072
+9,286
| +7% | +$84.7K |
2017 Q3
22 quarters
|
|
3717
Clearfield
CLFD
$447M
| $1.23M | ﹤0.01% |
26,386
+6,572
| +33% | +$423K |
2017 Q4
21 quarters
|
|
|
USDP
3718
DELISTED
USD PARTNERS LP
USDP
| $1.23M | ﹤0.01% |
409,201
-14,512
| -3% | -$48.9K |
2018 Q4
17 quarters
|
|
3719
Alignment Healthcare
ALHC
$1.77B
| $1.23M | ﹤0.01% |
192,944
+27,078
| +16% | +$258K |
2021 Q1
8 quarters
|
|
|
INVX
3720
Innovex International
INVX
$1.88B
| $1.23M | ﹤0.01% |
42,763
+7,904
| +23% | +$234K |
2013 Q2
39 quarters
|
|
3721
Takeda Pharmaceutical
TAK
$58.7B
| $1.22M | ﹤0.01% |
74,108
+57,166
| +337% | +$911K |
2018 Q4
17 quarters
|
|
3722
Green Brick Partners
GRBK
$2.78B
| $1.22M | ﹤0.01% |
34,817
+6,501
| +23% | +$201K |
2017 Q4
21 quarters
|
|
|
CUTR
3723
DELISTED
Cutera, Inc.
CUTR
| $1.21M | ﹤0.01% |
51,350
+2,030
| +4% | +$64.9K |
2016 Q4
25 quarters
|
|
3724
Vital Farms
VITL
$397M
| $1.21M | ﹤0.01% |
79,145
-18,954
| -19% | -$300K |
2020 Q3
10 quarters
|
|
3725
CALL
Olin
OLN
$1.81B
| $1.21M | ﹤0.01% |
+21,800
| New | +$1.25M |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.